ConductScience.org, home
Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis
API referenceFor AI assistants

Trial · NCT00730405

Participant flow30

How many started, completed or left each group, period by period.

1 to 20 of 30

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Overall Study-Treatment PhaseSTARTEDAlbaconazole 400 mg (36 Weeks) Oral Weekly116
Overall Study-Treatment PhaseSTARTEDAlbaconazole 400 mg (24 Weeks) Oral Weekly117
Overall Study-Treatment PhaseSTARTEDAlbaconazole 200 mg (36 Weeks) Oral Weekly117
Overall Study-Treatment PhaseSTARTEDAlbaconazole 100 mg (36 Weeks) Oral Weekly117
Overall Study-Treatment PhaseSTARTEDPlacebo115
Overall Study-Treatment PhaseCOMPLETEDAlbaconazole 400 mg (36 Weeks) Oral Weekly97
Overall Study-Treatment PhaseCOMPLETEDAlbaconazole 400 mg (24 Weeks) Oral Weekly96
Overall Study-Treatment PhaseCOMPLETEDAlbaconazole 200 mg (36 Weeks) Oral Weekly96
Overall Study-Treatment PhaseCOMPLETEDAlbaconazole 100 mg (36 Weeks) Oral Weekly98
Overall Study-Treatment PhaseCOMPLETEDPlacebo95
Overall Study-Treatment PhaseNOT COMPLETEDAlbaconazole 400 mg (36 Weeks) Oral Weekly19
Overall Study-Treatment PhaseNOT COMPLETEDAlbaconazole 400 mg (24 Weeks) Oral Weekly21
Overall Study-Treatment PhaseNOT COMPLETEDAlbaconazole 200 mg (36 Weeks) Oral Weekly21
Overall Study-Treatment PhaseNOT COMPLETEDAlbaconazole 100 mg (36 Weeks) Oral Weekly19
Overall Study-Treatment PhaseNOT COMPLETEDPlacebo20
Overall Study-follow-up PhaseSTARTEDAlbaconazole 400 mg (36 Weeks) Oral Weekly116
Overall Study-follow-up PhaseSTARTEDAlbaconazole 400 mg (24 Weeks) Oral Weekly117
Overall Study-follow-up PhaseSTARTEDAlbaconazole 200 mg (36 Weeks) Oral Weekly117
Overall Study-follow-up PhaseSTARTEDAlbaconazole 100 mg (36 Weeks) Oral Weekly117
Overall Study-follow-up PhaseSTARTEDPlacebo115

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00730405/flow

API referenceFor AI assistants